Calamos Advisors’s VIROPHARMA INC VPHM Stock Holding History

Calamos Advisors’s Portfolio VPHM Stock Details VPHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-92,952	Closed	-$2.66M	–	651
2013 Q2	$2.66M	Buy	+92,952	New	+$2.45M	0.02%	368

Other funds holding VPHM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Calamos Advisors's VPHM Position: Q3 2013 in Review

Calamos Advisors sold out of VIROPHARMA INC (VPHM) in Q3 2013, closing a stake of 92,952 shares — an estimated $2.66M sold.

Calamos Advisors first reported a position in VPHM in Q2 2013 and held it in 1 quarter. The position peaked at $2.66M in Q2 2013. 191 funds tracked by Wall St. Rank hold VPHM as of Q3 2013.

Calamos Advisors reported no remaining VIROPHARMA INC position as of Q3 2013 after selling out during the quarter.
Calamos Advisors sold 92,952 VIROPHARMA INC shares in Q3 2013, an estimated $2.66M.
Calamos Advisors first reported a position in VIROPHARMA INC in Q2 2013 and held it in 1 quarter.
Calamos Advisors's VIROPHARMA INC position peaked at $2.66M in Q2 2013.
191 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q3 2013.

Based on Calamos Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.